Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
Georgina V. Long(Westmead Hospital), Helen Rizos(Macquarie University)
Cited by 385
Related Papers
The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma
|Nature Communications|2023|127
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma
|Nature Medicine|2025|55